Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis

James A. Madura, David F. Canal, Glen Lehman, Michael B. Farnell, Richard A. Prinz, Theodore X. O'Connell, Merrill T. Dayton

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Hypothesis: The purpose of this study was to see if a small (<7 mm) pancreatic duct could be dilated to an acceptable diameter, allowing lateral pancreaticojejunostomy to decompress the pancreatic duct and relieve pain, while preserving pancreatic endocrine and exocrine function. Design: Patients with chronic pancreatitis who had a small main pancreatic duct underwent progressive transampullary dilation of the duct and subsequent placement of an expandable metallic wall stent (wallstent; Boston Scientific Microvasive Division, Natick, Mass). Approximately 14 days later, a lateral pancreaticojejunostomy was done. Setting: A 400-bed university referral center hospital in an urban setting. Patients: Thirty-five patients were selected from a large group with chronic pancreatitis. Thirty-one had pancreas divisum. All patients had undergone transendoscopic sphincterotomies and stenting before being accepted into the study. All had endoscopic retrograde cholangiopancreatography - proven chronic pancreatitis, and all ducts were observed to be 7 mm or smaller. Interventions: Patients were selected after endoscopic sphincterotomy and stenting failed. Progressive transendoscopic duct dilation with plastic stents was carried out, and a 10-mm expandable metallic wall stent was placed prior to surgical decompression. Lateral pancreaticojejunostomy was performed. Main Outcome Measures: Patients were observed for pain relief, postoperative symptoms, analgesic use, glucose intolerance, and quality of life. All patients were seen or contacted by telephone, and their results were recorded. Results: There were no operative deaths, but 26% of patients had complications. Seventy-one percent of patients reported that their pain was better than preoperatively. Three patients had subsequent pancreatic surgery. No new cases of diabetes occurred except in the 2 patients who underwent total pancreatectomy. Conclusions: In general, most patients feel that their lives were improved by the procedure. A quarter of the patients no longer take narcotics, and many have been able to resume a relatively normal lifestyle. Although this procedure is not a panacea for all patients with chronic pancreatitis and a nondilated duct, it is a reasonable alternative to resection.

Original languageEnglish
Pages (from-to)644-650
Number of pages7
JournalArchives of Surgery
Volume138
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Pancreaticojejunostomy
Pancreatitis
Stents
Chronic Pancreatitis
Pancreatic Ducts
Dilatation
Endoscopic Sphincterotomy
Surgical Decompression
Pain
Pancreatectomy
Glucose Intolerance
Endoscopic Retrograde Cholangiopancreatography
Urban Hospitals
Narcotics
Postoperative Pain

ASJC Scopus subject areas

  • Surgery

Cite this

Madura, J. A., Canal, D. F., Lehman, G., Farnell, M. B., Prinz, R. A., O'Connell, T. X., & Dayton, M. T. (2003). Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis. Archives of Surgery, 138(6), 644-650. https://doi.org/10.1001/archsurg.138.6.644

Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis. / Madura, James A.; Canal, David F.; Lehman, Glen; Farnell, Michael B.; Prinz, Richard A.; O'Connell, Theodore X.; Dayton, Merrill T.

In: Archives of Surgery, Vol. 138, No. 6, 01.06.2003, p. 644-650.

Research output: Contribution to journalArticle

Madura, JA, Canal, DF, Lehman, G, Farnell, MB, Prinz, RA, O'Connell, TX & Dayton, MT 2003, 'Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis', Archives of Surgery, vol. 138, no. 6, pp. 644-650. https://doi.org/10.1001/archsurg.138.6.644
Madura, James A. ; Canal, David F. ; Lehman, Glen ; Farnell, Michael B. ; Prinz, Richard A. ; O'Connell, Theodore X. ; Dayton, Merrill T. / Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis. In: Archives of Surgery. 2003 ; Vol. 138, No. 6. pp. 644-650.
@article{600f0e1d8f9e45ae9cd9b86344f5a3a1,
title = "Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis",
abstract = "Hypothesis: The purpose of this study was to see if a small (<7 mm) pancreatic duct could be dilated to an acceptable diameter, allowing lateral pancreaticojejunostomy to decompress the pancreatic duct and relieve pain, while preserving pancreatic endocrine and exocrine function. Design: Patients with chronic pancreatitis who had a small main pancreatic duct underwent progressive transampullary dilation of the duct and subsequent placement of an expandable metallic wall stent (wallstent; Boston Scientific Microvasive Division, Natick, Mass). Approximately 14 days later, a lateral pancreaticojejunostomy was done. Setting: A 400-bed university referral center hospital in an urban setting. Patients: Thirty-five patients were selected from a large group with chronic pancreatitis. Thirty-one had pancreas divisum. All patients had undergone transendoscopic sphincterotomies and stenting before being accepted into the study. All had endoscopic retrograde cholangiopancreatography - proven chronic pancreatitis, and all ducts were observed to be 7 mm or smaller. Interventions: Patients were selected after endoscopic sphincterotomy and stenting failed. Progressive transendoscopic duct dilation with plastic stents was carried out, and a 10-mm expandable metallic wall stent was placed prior to surgical decompression. Lateral pancreaticojejunostomy was performed. Main Outcome Measures: Patients were observed for pain relief, postoperative symptoms, analgesic use, glucose intolerance, and quality of life. All patients were seen or contacted by telephone, and their results were recorded. Results: There were no operative deaths, but 26{\%} of patients had complications. Seventy-one percent of patients reported that their pain was better than preoperatively. Three patients had subsequent pancreatic surgery. No new cases of diabetes occurred except in the 2 patients who underwent total pancreatectomy. Conclusions: In general, most patients feel that their lives were improved by the procedure. A quarter of the patients no longer take narcotics, and many have been able to resume a relatively normal lifestyle. Although this procedure is not a panacea for all patients with chronic pancreatitis and a nondilated duct, it is a reasonable alternative to resection.",
author = "Madura, {James A.} and Canal, {David F.} and Glen Lehman and Farnell, {Michael B.} and Prinz, {Richard A.} and O'Connell, {Theodore X.} and Dayton, {Merrill T.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1001/archsurg.138.6.644",
language = "English",
volume = "138",
pages = "644--650",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Wall stent-enhanced lateral pancreaticojejunostomy for small-duct pancreatitis

AU - Madura, James A.

AU - Canal, David F.

AU - Lehman, Glen

AU - Farnell, Michael B.

AU - Prinz, Richard A.

AU - O'Connell, Theodore X.

AU - Dayton, Merrill T.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Hypothesis: The purpose of this study was to see if a small (<7 mm) pancreatic duct could be dilated to an acceptable diameter, allowing lateral pancreaticojejunostomy to decompress the pancreatic duct and relieve pain, while preserving pancreatic endocrine and exocrine function. Design: Patients with chronic pancreatitis who had a small main pancreatic duct underwent progressive transampullary dilation of the duct and subsequent placement of an expandable metallic wall stent (wallstent; Boston Scientific Microvasive Division, Natick, Mass). Approximately 14 days later, a lateral pancreaticojejunostomy was done. Setting: A 400-bed university referral center hospital in an urban setting. Patients: Thirty-five patients were selected from a large group with chronic pancreatitis. Thirty-one had pancreas divisum. All patients had undergone transendoscopic sphincterotomies and stenting before being accepted into the study. All had endoscopic retrograde cholangiopancreatography - proven chronic pancreatitis, and all ducts were observed to be 7 mm or smaller. Interventions: Patients were selected after endoscopic sphincterotomy and stenting failed. Progressive transendoscopic duct dilation with plastic stents was carried out, and a 10-mm expandable metallic wall stent was placed prior to surgical decompression. Lateral pancreaticojejunostomy was performed. Main Outcome Measures: Patients were observed for pain relief, postoperative symptoms, analgesic use, glucose intolerance, and quality of life. All patients were seen or contacted by telephone, and their results were recorded. Results: There were no operative deaths, but 26% of patients had complications. Seventy-one percent of patients reported that their pain was better than preoperatively. Three patients had subsequent pancreatic surgery. No new cases of diabetes occurred except in the 2 patients who underwent total pancreatectomy. Conclusions: In general, most patients feel that their lives were improved by the procedure. A quarter of the patients no longer take narcotics, and many have been able to resume a relatively normal lifestyle. Although this procedure is not a panacea for all patients with chronic pancreatitis and a nondilated duct, it is a reasonable alternative to resection.

AB - Hypothesis: The purpose of this study was to see if a small (<7 mm) pancreatic duct could be dilated to an acceptable diameter, allowing lateral pancreaticojejunostomy to decompress the pancreatic duct and relieve pain, while preserving pancreatic endocrine and exocrine function. Design: Patients with chronic pancreatitis who had a small main pancreatic duct underwent progressive transampullary dilation of the duct and subsequent placement of an expandable metallic wall stent (wallstent; Boston Scientific Microvasive Division, Natick, Mass). Approximately 14 days later, a lateral pancreaticojejunostomy was done. Setting: A 400-bed university referral center hospital in an urban setting. Patients: Thirty-five patients were selected from a large group with chronic pancreatitis. Thirty-one had pancreas divisum. All patients had undergone transendoscopic sphincterotomies and stenting before being accepted into the study. All had endoscopic retrograde cholangiopancreatography - proven chronic pancreatitis, and all ducts were observed to be 7 mm or smaller. Interventions: Patients were selected after endoscopic sphincterotomy and stenting failed. Progressive transendoscopic duct dilation with plastic stents was carried out, and a 10-mm expandable metallic wall stent was placed prior to surgical decompression. Lateral pancreaticojejunostomy was performed. Main Outcome Measures: Patients were observed for pain relief, postoperative symptoms, analgesic use, glucose intolerance, and quality of life. All patients were seen or contacted by telephone, and their results were recorded. Results: There were no operative deaths, but 26% of patients had complications. Seventy-one percent of patients reported that their pain was better than preoperatively. Three patients had subsequent pancreatic surgery. No new cases of diabetes occurred except in the 2 patients who underwent total pancreatectomy. Conclusions: In general, most patients feel that their lives were improved by the procedure. A quarter of the patients no longer take narcotics, and many have been able to resume a relatively normal lifestyle. Although this procedure is not a panacea for all patients with chronic pancreatitis and a nondilated duct, it is a reasonable alternative to resection.

UR - http://www.scopus.com/inward/record.url?scp=0037647190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037647190&partnerID=8YFLogxK

U2 - 10.1001/archsurg.138.6.644

DO - 10.1001/archsurg.138.6.644

M3 - Article

VL - 138

SP - 644

EP - 650

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 6

ER -